Chinese Journal of Tissue Engineering Research ›› 2010, Vol. 14 ›› Issue (5): 883-886.doi: 10.3969/j.issn.1673-8225.2010.05.029

Previous Articles     Next Articles

Evaluation of the safety of living-related donor kidney transplantation: A 38-case analysis within 2 years

Lai Yan-hua, Sun Xu-yong, Nie Feng, Tan Qin, Dong Jian-hui, Li Zhuang-jiang   

  1. Department of Organ Transplantation Center, the 303 Hospital of Chinese PLA, Nanning 530021, Guangxi Zhuang Autonomous Region, China
  • Online:2010-01-29 Published:2010-01-29
  • Contact: Sun Xu-yong, Doctor, Chief physician, Master’s supervisor, Department of Organ Transplantation Center, the 303 Hospital of Chinese PLA, Nanning 530021, Guangxi Zhuang Autonomous Region, China xywn@sohu.com
  • About author:Lai Yan-hua★, Master, Attending physician, Department of Organ Transplantation Center, the 303 Hospital of Chinese PLA, Nanning 530021, Guangxi Zhuang Autonomous Region, China laiyanhua303@sina.com
  • Supported by:

     the Tackle Key Program in Science and Technology of Guangxi Zhuang Autonomous Region, No. 0719006-2-7*

PDF

459

Abstract:

BACKGROUND: Security of organ donor attracts more attention, because donor complication and transplantation failure always occur following renal transplantation. Therefore, living-related kidney transplantation should be paid much attention in order to make sure life and quality of life.
OBJECTIVE: To investigate the safety of living-related kidney transplantation.
METHODS: A total of 38 cases of living relative donor kidney transplantation were retrospectively analyzed. Before transplantation, identify of patients should be determined, and all patients provided the informed consent. The general data of patients were sufficiently dialyzed before transplantation to improve the body status. Tacrolimus or mixture of cyclosporine A, mycophenolate, and adrenal cortex hormone were administrated following transplantation to observe renal function, complication incidence, and acute rejection reaction.
RESULTS AND CONCLUSION: Due to short waiting time, low price, and long-term survival rate, living-relative donor kidney transplantation has low risk factors for donor. However, the safety still needs to be sufficiently evaluated for donors and recipients.

CLC Number: